MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Acute parkinsonism following an obstructive hydrocephalus and a ventriculoperitoneal shunt revision: a case report

    J. Majuri, HR. Maanpää, A. Kotkansalo, J. Korpela, J. Joutsa (Lahti, Finland)

    Objective: To describe a case of acute parkinsonism following an obstructive hydrocephalus and ventriculoperitoneal (VP) shunt revision. Background: Acute parkinsonism is a rare complication of…
  • 2019 International Congress

    Repetitive transcranial magnetic stimulation can improve anxiety in Parkinson’s disease: a randomized, double-blind and controlled trial

    A. Makkos-Weisz, N. Kovács, P. Endre, M. Kovács, D. Pintér (Pécs, Hungary)

    Objective: High frequrncy (HF) repetitive transcranial magnetic stimulation (rTMS) improve anxiety in Parkinson’s Disease (PD). Background: The high frequency repetitive transcranial magnetic stimulation above the…
  • 2019 International Congress

    High intensity interval training elevates circulating BDNF and miRNAs level in patients with idiopathic Parkinson’s disease

    P. Malczynska, B. Kaminski, M. Siemiatycka, A. Pawłowska, I. Przybylska, J. Langfort, J. Marusiak, M. Chalimoniuk (Warsaw, Poland)

    Objective: To investigate if twelve weeks of high intensity interval training (HIIT) can enhance serum  BDNF and miRNAs levels in patients with Parkinson’s disease (PD). Background: BDNF plays several important physiological functions including…
  • 2019 International Congress

    K0706, A Potent Orally Bioavailable Brain-Penetrating Selective Inhibitor of cABL Protein Tyrosine Kinase, Exhibits Neuroprotective Activity in Preclinical Models of Parkinson’s Disease

    S. Mandhane, D. Soni, K. Jani, P. Sengupta, A. Patel, R. Bambal, V. Ramanathan, Y. Zala, N. Dharmadhikari, C. Rao, A. Raghavan, N. Damle (Vadodara, India)

    Objective: Preclinical assessment of K0706, a potent c-Abl inhibitor, as a neuroprotective disease modifying agent for the treatment of Parkinson’s disease (PD) related neurodegeneration using…
  • 2019 International Congress

    Machine learning classifiers and subjective vocal perception of Parkinson’s disease patients and healthy control

    Y. Manor, S. Naor, D. Shpunt, N. Diamant, A. Hillel, A. Ezra, I. Opher, Y. Hauptman, R. Aloni-Lavi, A. Faust-Socher, H. Shabtai, R. Peled, A. Migirov, T. Gurevich (Tel Aviv, Israel)

    Objective: To identify machine learning classifiers and to assess the acoustic differences between PD patients and healthy control (HC) and the relations between objective and…
  • 2019 International Congress

    Utility of Eye Movement Abnormalities in Differentiating Neurodegenerative versus non-Neurodegenerative Parkinsonism

    A. Margolius, D. Hengartner, O. Hogue, X. Garcia, S. Patel, A. Ahmed, H. Fernandez, XX. Yu (Bogota, Colombia)

    Objective: To evaluate eye movement abnormalities in patients with neurodegenerative versus non-neurodegenerative parkinsonism. Background: Clinical distinction between neurodegenerative and non-neurodegenerative parkinsonism can be difficult[1]. Eye…
  • 2019 International Congress

    Automated Metabolic Pattern Analysis in the Differential Diagnosis of Parkinsonism in a Swedish Cohort

    I. Markaki, C. Tang, M. Lilja Lindström, D. Eidelberg, P. Svenningsson, I. Savitcheva (Stockholm, Sweden)

    Objective: To assess the accuracy of an automated, disease-specific, pattern model to distinguish among PD, MSA and PSP, in comparison with the final clinical diagnosis.…
  • 2019 International Congress

    Sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy

    L. Marques, V. Silva, J. Araújo, S. Varanda, G. Carneiro, M. Rodrigues (Braga, Portugal)

    Objective: To compare the diagnostic sensitivity of hummingbird and morning glory signs with that of the midbrain area and the midbrain to pons area ratio.To…
  • 2019 International Congress

    Tau and amyloid-beta inclusions are present in pancreatic beta-cells of patients with synucleinopathies

    I. Martinez-Valbuena, R. Valenti-Azcarate, J. Sanchez, I. Marcilla Garcia, I. Amat-Villegas, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)

    Objective: We have assessed whether tau and amyloid beta deposits might be present in pancreatic tissue of subjects with Parkinson’s and Lewy Body dementia. Background:…
  • 2019 International Congress

    Amylin deposition in the brain of Parkinson’s disease patients

    I. Martinez-Valbuena, R. Valenti-Azcarate, J. Sanchez, I. Marcilla Garcia, G. Marti Andres, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)

    Objective: The objective of this study was to determine the presence of amylin deposits in the brain of subjects with synucleinopathies. Background: The link between…
  • « Previous Page
  • 1
  • …
  • 1288
  • 1289
  • 1290
  • 1291
  • 1292
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley